You are in: eMedicine Specialties > Dermatology > ENVIRONMENTAL Fire Ant BitesArticle Last Updated: Jun 11, 2007AUTHOR AND EDITOR INFORMATIONAuthor: James P Ralston, MD, Resident, Department of Dermatology, State University of New York at Buffalo School of Medicine and Biomedical Sciences James P Ralston is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine, American Medical Association, and Texas Medical Association Coauthor(s): Ronald P Rapini, MD, Professor and Chair, Professor of Pathology, Department of Dermatology, University of Texas Medical School, MD Anderson Cancer Center Editors: Daniel Hogan, MD, Chief of Dermatology, Professor, Departments of Internal Medicine and Pediatrics, Louisiana State University Medical Center; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Jeffrey J Miller, MD, Associate Professor, Department of Dermatology, Penn State University, Milton S Hershey Medical Center; Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System Author and Editor Disclosure Synonyms and related keywords: Solenopsis invicta, S invicta, Solenopsis richteri, S richteri, Solenopsis saevissima, S saevissima, Solenopsis geminata, S geminata, Solenopsis xyloni, S xyloni, Hymenoptera, hypersensitivity reactions, secondary infections, dialkylpiperidine hemolytic factors, allergenic proteins, Soli 1-4, anaphylaxis, anaphylactic reaction, fireant-induced anaphylaxis, INTRODUCTIONBackgroundThe fire ant is a wingless member of the order Hymenoptera, which includes wasps and bees. It is a potentially lethal environmental hazard in the United States, infesting more than 310 million acres of land. Fire ants are resistant to control efforts and can overwhelm an environment. They damage farm equipment, electrical systems, irrigation systems, and land. They build mounds in sunny, open areas (eg, lawns, playgrounds, parks, golf courses) and aggressively attack anyone who disrupts their mound. Fire ants are thought to have arrived in the United States between 1918 and the 1930s from South America by ships that docked in Mobile, Alabama. They are now found throughout the Southeast and are migrating rapidly. One contributing factor to this expansion is progressive urbanization in the United States, which creates the type of disturbed habitat that the fire ants prefer. Their mobility and ability to establish colonies in diverse habitats makes the detection of new infestations difficult. Sometimes, colonies exist several years before detection. Each year, fire ants sting more than one half of the population in endemic areas of the Southeast. They cause a variety of medical problems, including increasing numbers of hypersensitivity reactions, secondary infections, neurologic complications, and even death. PathophysiologyThe fire ant uses its mandibles to grasp its victim. It arches its body and drives an abdominal stinger into the skin to release venom. If not quickly removed, it then pivots around its mandibles and inflicts further stings in a circular pattern. The stinger is a modified ovipositor that consists of a dorsal stylet and 2 ventrolateral lancets. These structures surround the venom canal, which connects to the venom sac. A pair of coiled glands produces the venom that discharges into the venom sac. Fire ant venom differs from bee and wasp venom, which are mostly proteinaceous solutions. About 95% of fire ant venom is water-insoluble, is nonproteinaceous, and contains dialkylpiperidine hemolytic factors. These hemolytic factors induce the release of histamine and other vasoactive amines from mast cells, resulting in a sterile pustule at the sting site. These alkaloids are not immunogenic, but their toxicity to the skin is believed to cause the pustules to form. The venom also contains several allergenic proteins, measuring about 1.5% by dry weight. Four major allergenic proteins exist; Soli 1-4 induce immunoglobulin E (IgE) responses, including anaphylaxis, in patients who are allergic. Antigenic similarity exists between these proteins and bee and wasp venoms. Many patients have venom-specific IgE-mediated wheal and flare reactions that develop over hours into pruritic edematous, indurated, and erythematous lesions that persist for up to 72 hours. These lesions may involve an entire extremity. They histologically resemble late-phase mast cell–dependent reactions and show an infiltrate of eosinophils, neutrophils, and fibrin deposition. Large, local reactions rarely can cause edematous tissue compression, leading to vascular compromise of an extremity. FrequencyUnited StatesBecause most fire ant stings are not severe enough to cause the victim to seek medical attention, estimating the frequency of stings is difficult; however, annually, more than one half of the population in endemic areas is stung, and the incidence appears to be increasing. Mortality/MorbidityFire ants are becoming an increasingly important public health concern in the United States. More than 80 fatalities have been reported from fire ant-induced anaphylaxis. RaceFire ant stings may occur in people of any race. No race has been shown to have an increased risk of being stung or to have a higher predisposition to complications. SexFire ants sting both males and females without discrimination. AgeFire ants sting people of all ages, but children are overrepresented, probably because of greater environmental exposure. CLINICALHistory
PhysicalPhysical findings from fire ant bites and stings can be subdivided into local and systemic reactions.
CausesThe fire ant prefers open, sunny areas, such as pastures, parks, lawns, playgrounds, golf courses, and fields. Colonies also occur in or around buildings. Mound building increases considerably during warm months of the year when soil is moist. Concentrations in some areas exceed 200 mounds per acre. Several risk factors have been identified:
DIFFERENTIALSAcneiform Eruptions Acropustulosis of Infancy Bedbug Bites Black Widow Spider Bite Brown Recluse Spider Bite Bullous Disease of Diabetes Candidiasis, Cutaneous Cellulitis Chickenpox Cutaneous Larva Migrans Drug-Induced Bullous Disorders Eosinophilic Pustular Folliculitis Erythema Toxicum Neonatorum Folliculitis Herpes Simplex Herpes Zoster Insect Bites Linear IgA Dermatosis Psoriasis, Pustular Seabather's Eruption Subcorneal Pustular Dermatosis Transient Neonatal Pustular Melanosis Urticaria, Cholinergic
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Diphenhydramine (Benadryl, Benylin) |
|---|---|
| Description | For symptomatic relief of symptoms caused by release of histamine in allergic reactions. |
| Adult Dose | 25-50 mg PO qid for local reactions 25-50 mg IV/IM for urticaria, wheezing, and angioedema |
| Pediatric Dose | <2 years: Not established 2-6 years: 6.25-12.5 mg PO q4-6h 6-12 years: 12.5-25 mg PO q4-6h >12 years: 25-50 mg PO q4-6h |
| Contraindications | Documented hypersensitivity; acute asthma; newborns; breastfeeding |
| Interactions | Potentiates effect of CNS depressants; because of alcohol content, do not give syr dosage form to patient taking medications that can cause disulfiramlike reactions; concomitant alkaloids present in belladonna, antidepressants with strong anticholinergic effects (eg, amitriptyline, trimipramine, amoxapine, doxepin, imipramine, nortriptyline, maprotiline), or phenothiazines with strong anticholinergic effects (eg, chlorpromazine, triflupromazine, thioridazine) and antihistamines may increase possibility of adynamic ileus, urinary retention, or chronic glaucoma (more prominent in elderly patients) |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, and urinary tract obstruction; elderly more susceptible to side effects; caution in history of bronchial asthma, cardiovascular disease or hypertension; may cause excitation in young children |
These agents relieve pain and reduce inflammation.
| Drug Name | Ibuprofen (Ibuprin, Advil, Motrin) |
|---|---|
| Description | Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis. |
| Adult Dose | 400 mg PO q4-6h prn |
| Pediatric Dose | 4-10 mg/kg PO q6-8h prn |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI tract bleeding or perforation; high risk of bleeding; renal insufficiency |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Class D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy |
These agents have anti-inflammatory properties and cause profound and varied metabolic effects. Corticosteroids modify the body's immune response to diverse stimuli. A short course may be used for severe local reactions.
| Drug Name | Prednisone (Deltasone, Orasone, Sterapred) |
|---|---|
| Description | May decrease inflammation by reversing increased capillary permeability and suppressing PMN activity. Many dosing regimens have been used. |
| Adult Dose | 20 mg PO qd for 5 d |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; viral, fungal, tubercular skin, or connective tissue infections; peptic ulcer disease; hepatic dysfunction; GI tract disease |
| Interactions | Coadministration with estrogens may decrease clearance; concurrent use with digoxin may cause digitalis toxicity secondary to hypokalemia; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Abrupt discontinuation of glucocorticoids may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur |
This agent is used for anaphylaxis reactions.
| Drug Name | Epinephrine (EpiPen, Adrenalin) |
|---|---|
| Description | DOC for treating anaphylactoid reactions. Has alpha-agonist effects that include increased peripheral vascular resistance, reversed peripheral vasodilatation, systemic hypotension, and vascular permeability. Beta-agonist effects of epinephrine include bronchodilatation, chronotropic cardiac activity, and positive inotropic effects. |
| Adult Dose | 0.1-0.5 mg IM/SC q10-15min (1:1000 solution) Autoinjector: 0.3 mg IM (0.3 mL of 1:1000 sol); may repeat if severe anaphylaxis persists Injectable sol: 0.2 to 1 mg SC |
| Pediatric Dose | Neonates: 0.01-0.03 mg/kg IV/ET q3-5min prn Infants/children: 0.01 mg/kg IM once; alternatively, 0.15 to 0.3 mg IM depending on body weight; 0.01 mg/kg may be appropriate for patients weighing <30 kg |
| Contraindications | Documented hypersensitivity; cardiac arrhythmias or angle-closure glaucoma; local anesthesia in areas such as fingers or toes because vasoconstriction may produce sloughing of tissue; during labor (may delay second stage of labor); cardiac dilatation and coronary insufficiency (injection); concurrent use with cyclopropane or halogenated hydrocarbon anesthetic |
| Interactions | Alpha-blockers antagonize vasoconstriction; antihistamines may potentiate adverse cardiac effects; beta-blockers antagonize effects; cyclopropane may increase risk of arrhythmias; digoxin may increase risk of arrhythmias; ergot alkaloids increase risk of severe hypertension; halothane may increase risk of arrhythmias; TCAs may potentiate adverse cardiac effects; thyroid hormones may potentiate adverse cardiac effects; concurrent administration with chlorpromazine may result in decrease in blood pressure with reflex tachycardia Chlorpromazine may reduce effect by approximately 50%; coadministration with MAOI including linezolid may cause clinically significant hypertensive effects; concurrent use of guanethidine and direct-acting sympathomimetic amines (eg, epinephrine, methoxamine, norepinephrine, phenylephrine) can result in severe hypertension |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Caution in elderly persons, prostatic hypertrophy, hypertension, cardiovascular disease, diabetes mellitus, hyperthyroidism, and cerebrovascular insufficiency; rapid IV infusions may cause death from cerebrovascular hemorrhage or cardiac arrhythmias |
| Media file 1: Imported fire ant national distribution map. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Image |
| Media file 2: Red imported fire ant worker. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 3: Fire ant mound in lawn. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 4: Venom sac and stinger of a fire ant. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 5: Fire ant worker biting and stinging. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 6: Pustules and blisters formed following fire ant stings on the arm. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 7: Pustules and blisters formed following fire ant stings on the hand. From http://fireant.tamu.edu. Reproduced with permission from B.M. Drees, Texas Imported Fire Ant Project Coordinator, Texas A&M University, College Station, Texas. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 8: Fire ant bites on the foot. | |
![]() | View Full Size Image | Media type: Photo |
Article Last Updated: Jun 11, 2007